Navigation Links
Examination of lymph nodes provides more accurate breast cancer prognosis
Date:7/29/2013

After a breast cancer operation, the removed tumour is always examined, as its subtype can provide an indication of how aggressive the disease is. The patient's lymph nodes are not analysed in the same way. Yet the breast tumour can sometimes appear to be of a less aggressive type while the subtype in the lymph nodes gives a different and more worrying picture.

In these cases, it is the lymph nodes that provide the correct prognosis, according to new research at Lund University in Sweden. An analysis of the proliferation, hormone receptor status and HER2 status of the lymph nodes would in many cases show a significantly more accurate picture of the risk of metastases, i.e. a recurrence of the disease and its spreading to other organs.

"It would be easy to add such an analysis. It does not require any expensive specialist technology, but only an extension of the normal, routine pathology work", says Lisa Rydn, a consultant surgeon and researcher at Lund University.

The study covers 500 women in the early stages of breast cancer who underwent surgery in Lund or Helsingborg. Early-stage breast cancer is when the cancer has not yet spread to other organs. However, in approximately one third of all the women who underwent surgery for early-stage breast cancer, there were traces of the tumour in the lymph nodes, which can provide important additional information.

"Sometimes the molecular study showed the same subtype in the breast tissue and in the lymph nodes. But sometimes the types were different. And when we investigated the outcomes for the women 10 years later, the prognosis followed the subtype that was present in the lymph nodes and not the one in the breast", says Lisa Rydn.

Thus when doctors only examine the breast tissue, there is a risk that the tumour will be found to be of a low-risk type, which affects decisions on further treatment. The lymph nodes may meanwhile show signs of a more aggressive form of tumour, but that is never discovered.

"If, on the other hand, we start routinely analysing the lymph nodes as well, we can treat women in such cases with additional cytostatic and targeted drugs after their operation. This could prevent later recurrence of the disease" thinks Lisa Rydn.

A fairly small proportion of the patients in the study showed a difference in tumour type between the breast tissue and the lymph nodes. But since breast cancer is such a common disease, the number of patients affected nationally and globally will still be considerable and, for them, the difference can be that between life and death, the Lund researcher points out.


'/>"/>

Contact: Lisa Rydén
lisa.ryden@med.lu.se
46-706-720-923
Lund University
Source:Eurekalert

Related medicine news :

1. North American Seminars Receives NY State Approval for a New Physical Therapy Online Continuing Education Course, Examination and Treatment of the SI Joint
2. North American Seminars Introduces a New Online Continuing Education Course for Physical Therapists, Examination and Treatment of the Hip Joint
3. North American Seminars Introduces Vestibular Rehabilitation - Examination and Treatment, a New Physical Therapy Online Continuing Education Course
4. North American Seminars Introduces a New Online Continuing Education Course for Physical Therapists, Examination and Treatment of the SI Joint
5. Sharing examination questions threatens trust in medical profession
6. Report offers an in-depth examination of health centers role in family planning
7. Decision support system translates into high percentage of positive chest CT examinations
8. HIV-associated lymphoma survival has not improved during the antiretroviral therapy era
9. North Shore-LIJ Health System's Feinstein Institute to Receive $250,000 Grant from Lymphoma Research Foundation Grant to support research of Chronic Lymphocytic Leukemia
10. Innovative Technique Seeks to Prevent Lymphedema in Breast Cancer Patients
11. Radioimmunotherapy deemed safe and effective for lymphoma patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Bill Mull Agencies, ... owners in and around central Kansas, is joining the Youth Horizons organization for ... region. , Headquartered in Wichita, Youth Horizons works to empower area children from ...
(Date:12/7/2016)... ... ... Kenall Manufacturing, a leader in sealed healthcare lighting for more than 30 ... sealed, LED luminaire that meets the needs of everyone in the patient room by ... , A 2’ x 4’ model features four modes: reading, ambient, standard and high ...
(Date:12/7/2016)... ... December 07, 2016 , ... OC87 Recovery Diaries ... schizophrenic mother in a unique, personal perspective through animation. , That woman ... addictive disorders at her private psychotherapy practice. Sheri’s mother, Pearl, lived with schizophrenia. ...
(Date:12/7/2016)... ... 07, 2016 , ... Castle Dermatology Institute is now offering liquid facelifts with ... youthful appearance to the face. Dr. Peyman Ghasri and Dr. Pedram Ghasri, San ... treatments, to rejuvenate and renew the facial appearance. , Sculptra is a highly ...
(Date:12/7/2016)... Fl (PRWEB) , ... December 07, 2016 , ... When it came time to blow ... heart. Just 40 minutes later, the Pediatric Heart Transplant team at Joe DiMaggio ... making the Weston teen the hospital’s 30th heart transplant recipient. , “He was playing ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... DALLAS , Dec. 8, 2016 Dignitana, ... an exclusive partnership with Boa® Technology, creator of the ... fit cap for use with the DigniCap® scalp cooling ... Drug Administration in December 2015, and is the first ... The DigniCap® scalp cooling system features a patented ...
(Date:12/8/2016)... 8, 2016  Economic growth in the United States ... supply management executives in their December 2016 Semiannual Economic ... recovery that began in mid-2009, as indicated in the ... ® . The manufacturing sector is optimistic about growth ... manufacturing industries, and the non-manufacturing sector indicates that 14 ...
(Date:12/8/2016)... PUNE, India , December 8, 2016 According ... (Diagnostic (Heart, Pulse, BP, Sleep, Fetal), Therapeutic (Pain, Insulin)), End Use (Sports, ... to 2021", published by MarketsandMarkets, the global market, in terms of value, ... in 2016, at a CAGR of 18.0% during the forecast period. ... ...
Breaking Medicine Technology: